Stockreport

Dyne Therapeutics Inc (DYN) Reports Encouraging Clinical Data and Financial Growth for Q4 and ... [Yahoo! Finance]

Dyne Therapeutics, Inc.  (DYN) 
Last dyne therapeutics, inc. earnings: 11/1 04:30 pm Check Earnings Report
US:NYSE Investor Relations: dynegy.com/investors/presentations-events
PDF G&A Expenses : Rose to $8.8 million in Q4 2023 compared to $7.0 million in Q4 2022. Net Loss : Grew to $66.6 million in Q4 2023, or $1.09 per share, from $38.8 millio [Read more]